Verition Fund Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Verition Fund Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-51,693	Closed	-$815K	–	3048
2023 Q4	$815K	Buy	+51,693	New	+$498K	0.01%	1272
2023 Q2	–	Sell	-10,058	Closed	-$58.3K	–	2663
2023 Q1	$58.3K	Buy	+10,058	New	+$86.9K	﹤0.01%	1950

Verition Fund Management's ICVX Position: Q1 2024 in Review

Verition Fund Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 51,693 shares — an estimated $815K sold.

Verition Fund Management first reported a position in ICVX in Q1 2023 and held it in 2 quarters. The position peaked at $815K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Verition Fund Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Verition Fund Management sold 51,693 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $815K.
Verition Fund Management first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Verition Fund Management's Icosavax, Inc. Common Stock position peaked at $815K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.